Endogenous IFNß expression predicts outcome in critical patients with COVID-19.

Menezes, Soraya Maria; Braz, Marcos; Llorens-Rico, Veronica; Wauters, Joost; Van Weyenbergh, Johan

Menezes, Soraya Maria; Braz, Marcos; Llorens-Rico, Veronica; Wauters, Joost; Van Weyenbergh, Johan.

Afiliação

Menezes SM; Laboratory of Clinical and Epidemiological Virology, KU Leuven, 3000 Leuven, Belgium.
Braz M; Laboratory of Clinical and Epidemiological Virology, KU Leuven, 3000 Leuven, Belgium.
Llorens-Rico V; Laboratory of Bacteriology, KU Leuven, 3000 Leuven, Belgium.
Wauters J; Department of Microbiology, Immunology and Transplantation, Rega Institute of Medical Research and Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
Van Weyenbergh J; University Hospitals Leuven, Leuven, Belgium.

Lancet Microbe ; 2(6): e235-e236, 2021 06.

Article em En | MEDLINE | ID: mdl-33817674

Assuntos

COVID-19; Interferon beta/metabolismo; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon beta / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Microbe Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google